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Abstract
Genetic quality assurance (QA), including genetic monitoring (GeMo) of inbred strains and background char-
acterization (BC) of genetically altered (GA) animal models, should be an essential component of any QA
programme in laboratory animal facilities. Genetic quality control is as important for ensuring the validity of
the animal model as health and microbiology monitoring are. It should be required that studies using labora-
tory rodents, mainly mice and rats, utilize genetically defined animals. This paper, presented by the FELASA
Working Group on Genetic Quality Assurance and Genetic Monitoring of Laboratory Murines, describes the
objectives of and available methods for genetic QA programmes in rodent facilities. The main goals of any
genetic QA programme are: (a) to verify the authenticity and uniformity of inbred stains and substrains, thus
ensuring a genetically reliable colony maintenance; (b) to detect possible genetic contamination; and (c) to
precisely describe the genetic composition of GA lines. While this publication focuses mainly on mouse and
rat genetic QA, the principles will apply to other rodent species some of which are briefly mentioned within the
context of inbred and outbred stocks.
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Standardized laboratory rodents
Inbred strains
The International Committee on Standardized Genetic
Nomenclature for Mice and The Rat Genome
Nomenclature Committee considers a strain inbred
if it has been propagated by systematically mating
brothers to sisters (or younger parent to oﬀspring) for
20 or more consecutive generations, and individuals of
the strain can be traced to a single ancestral pair at the
twentieth or subsequent generation.
At this point, animals within the population will aver-
age2% residual heterozygosity, and the individuals
may be regarded as genetically identical (isogenic).1
However, it has been estimated that 24 generations of
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sib-mating are needed to reach a heterozygosity rate-
< 1% and 36 generations to reach (almost) complete
isogeneity.2
Isogeneity implies histocompatibility, meaning the
strains are syngeneic. Syngeneic animals will perman-
ently accept tissue transplants from any individual of
the same strain and sex. Unlike cloned animals and
monozygotic twins (which are 100% identical for all
genomic loci), inbred rodents, besides being isogenic,
are also homozygous at almost all genomic loci.
Overall, each inbred strain represents a unique,
although fortuitous, assortment of alleles.3 If a strain
were to be remade from scratch, using the same foun-
ders, after the same 20 generations of inbreeding it
would create a genetically distinct strain due to the
random assortment and ﬁxation of alleles. Baseline
phenotypic data for the most common inbred mouse
strains are available through a coordinated inter-
national eﬀort initiated by The Jackson Laboratory
and implemented through The Mouse Phenome
Database (http://phenome.jax.org/).4 An example of
baseline phenotypic data is presented in
Supplementary Tables 1A and 1B. The Mouse
Genome Informatics (MGI) website5 provides a list,
compiled by Dr Michael Festing (http://www.informat-
ics.jax.org/external/festing/search_form.cgi), of 420
inbred mouse and 230 inbred rat strains (some of
which have been lost or terminated), along with brief
descriptions. The list includes widely used inbred mouse
strains: A/J, BALB/c, C3H/He, C57BL/6, DBA/2,
FVB/N and others; and rat strains: ACI, BN, F344,
LE and WKY.
Outbred stocks
Outbred stocks are populations of laboratory animals
that diﬀer from inbred strains in that they are genetic-
ally heterogeneous. Compared with inbred strains or
F1 hybrids, the genetic constitution of a given animal,
taken randomly from an outbred stock, is not known a
priori. However, all of the animals in the group share
group characteristics (identity), such as being albino
(although not all outbred mice or rats are albino),
good breeders and relatively tame compared to other
strains; features that make these animals very popular
as foster mothers for assisted reproductive techniques.
Examples of outbred stocks of mice are ICR (CD-1),
CFW and NMRI (all derived from the original ‘Swiss’
mice imported to the USA by Clara J. Lynch in 1926)
and (non-Swiss) CF-1. Examples of outbred rat stocks
are Sprague Dawley (SD), Wistar (WI) and Long-
Evans (LE). Since outbred stocks are not genetically
deﬁned, quality control is commonly based on assessing
expected phenotypic traits, such as coat colour, growth
and reproductive characteristics, based on data from
the large colonies of commercial breeders. Because
outbred colonies, like human populations, are hetero-
geneous, they are frequently used in toxicology and
pharmacology research.6 However, several geneticists
have disputed this use and have criticized studies in
which outbred mice were used inappropriately, wasting
both animal lives and precious resources in suboptimal
experiments.7
Other standardized strains of mice and rats
F1 hybrids result from the outcross of two separate
inbred strains and are heterozygous at all loci for
which the parental strains harbour diﬀerent alleles. F1
littermates are genetically identical and are histocom-
patible. Congenic strains are produced by crossing two
strains: the donor strain that carries the allele or
chromosomal region of interest, and the recipient or
background strain that will receive the locus of interest.
F1 oﬀspring generated by crossing donors and recipi-
ents are then backcrossed to the recipient strain.
Oﬀspring that carry the allele of interest are identiﬁed
and again backcrossed to the background strain. This
process is typically repeated for 10 or more successive
generations (Figure 1), unless marker-assisted back-
crosses (speed congenics) are used. Repeated backcross-
ing results in the chromosomes of the background
strain progressively replacing those of the donor
strain, except for a chromosomal region that carries
the allele of interest.
Genetically altered (GA) rodents
Before presenting the diﬀerent types of GA rodents, it
is worth mentioning that there are basically two diﬀer-
ent approaches to characterizing gene function.
Forward genetics (from phenotype to genotype) aims
to characterize the gene alteration that is responsible
for a speciﬁc mutant phenotype (typically from spon-
taneous or chemically-induced mutations). Reverse gen-
etics is the opposite approach and aims to characterize
the function of a gene by analysing the consequences (at
the phenotypic level) of alterations normally engineered
by researchers at the DNA level. This section intro-
duces the four basic types of GA rodents, those created
by: (a) pronuclear microinjection, (b) vector- mediated
transgenesis (c) homologous recombination in embry-
onic stem (ES) cells, (d) gene editing nucleases, and (e)
either chemically induced or spontaneous mutations.
Detailed descriptions of the technologies used to
create GAs have been published.8 Before selecting a
gene-editing technique to create a genetically modiﬁed
animal, it is important to check an appropriate data-
base such as those hosted by The Jackson Laboratories
and the International Mouse Phenotyping Consortium
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as to whether a suitable animal model already exists
(see Supplementary Table 2 for the complete list of
online resources for laboratory mouse and rat strains).
Transgenesis by pronuclear microinjection
Transgenic mice were introduced in the early 1980s9
and were the ﬁrst transgenic animals. It is advisable to
use the term ‘transgenic’ only for animals whose gen-
omes have been altered by the random insertion of
DNA. (There are numerous terms used to describe gen-
etic changes in animals: genetically engineered mice
(GEM) or genetically modiﬁed mice (GMM) are typic-
ally used to describe any type of genetic modiﬁcation in
the mouse. We use the term GA rodent here to also
include those carrying spontaneous or chemically
induced mutations, and ‘line’ instead of ‘strain’ for
GA rodents.) Transgenic rodents are almost exclusively
created by the pronuclear microinjection of foreign
DNA fragments directly into one of the two pronuclei
of one-cell embryos (zygote), a technique that is still
widely used. In this process of additive transgenesis,
the microinjected transgene randomly integrates into
the genome as a single copy or more often as a conca-
temer with variable copy number. The mouse and rat
models created with this system typically express or, in
the resultant concatemer, overexpress a transgene
placed under the control of a tissue-speciﬁc, develop-
mental-stage-speciﬁc, or ubiquitous promoter (along
with other regulatory elements), all contained in the
transgene DNA construct.
The recommended generic symbol for a transgenic
insertion is Tg. The founder transgenic animals are
hemizygous for the DNA segment and are designated
Tg/0. Transgenes are extra segments of DNA that have
no corresponding ‘wild-type’ sequence in the unmodi-
ﬁed homologous chromosome in hemizygous animals,
that is why the use of ‘0’ instead of ‘þ’ (typically used to
denote wild-type alleles) is recommended. Each trans-
genic line generated via random integration creates a
unique animal model and each putative founder must
be developed independently. Traditionally, to distin-
guish between homozygous (Tg/Tg) and hemizygous
(Tg/0) mice, the mouse of interest was crossed to a
non-transgenic partner and the progeny were statistic-
ally analysed for Mendelian segregation of the
transgene. A more modern technique uses quantitative
real-time polymerase chain reaction (qPCR) to distin-
guish hemizygous from homozygous transgenic mice.10
In order to achieve a pure genetic background (recom-
mended), the transgene must be introduced into
embryos derived from an inbred strain.
A later improvement on the constructs used in the
transgenesis approach was the introduction of inducible
systems in which transgene expression can be turned on
and oﬀ. Examples of this strategy are the Tet-on and
Tet-oﬀ expression systems. In these systems, transcrip-
tion of a given transgene is placed under the control of
a tetracycline-controlled trans-activator protein, which
can be regulated, both reversibly and quantitatively, by
exposing the transgenic mice to either Tetracycline (Tc)
or one of its derivatives, such as Doxycycline (Dox).
Both Tet-on and Tet-oﬀ are binary systems that require
the generation of double transgenic (bigenic) mice.11
Vector-mediated transgenesis
Alternative methods for transgenesis by random inte-
gration are based on vectors of diﬀerent origin. Most
important and very eﬃcient are retroviral/lentiviral vec-
tors12 and transposons.13 Also pre-treated spermatozoa
have been successfully used as vectors in combination
with ICSI (intracytoplasmic sperm injection).14 Each
technique has advantages and disadvantages and the
corresponding principle of transgene integration may
aﬀect the quality of the resulting GA models. Viral vec-
tors and transposons for instance integrate as a single
copy, however multiple integrations, randomly distrib-
uted in the genome, are not uncommon. Major con-
cerns exist regarding the impact of sperm-mediated
gene transfer on the sperm genetic material, possibly
induced by the pre-treatment of spermatozoa.15
Targeted mutagenesis by homologous
recombination using ES cells
Another important technology utilizes murine ES cell
lines. ES cells are undiﬀerentiated, pluripotent, embry-
onic cells derived from the inner cell mass of pre-
implantation blastocysts that can participate in forming
the germ-cell lineage of chimeric mice, an indispensable
step in generating founder mice carrying the targeted
mutation. Historically, the ﬁrst ES cell lines were
derived from embryos of the 129 family (129S2,
129P3, etc.), that is inbred strains originally bred for
the isolation of embryonic carcinoma (EC) cells. Today
ES cell lines are available from many mouse strains and
those of the C57BL/6N origin have become widespread
and are often selected for trans-national projects (e.g.
EUCOMM).
In cases where constitutive null alleles lead to com-
plex phenotypes, reduced viability, or have other draw-
backs, conditional alleles may be used, allowing one to
control the time and tissue where a gene is turned oﬀ,
typically using the Cre/loxP system.16 Production of
conditional KOs requires two independent lines: one
providing a source of Cre recombinase, an enzyme
derived from bacteriophage P1, in the tissue under
study, and another containing loxP (locus of X-ing
over P1) sites ﬂanking the DNA segment of interest
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that needs to be crossed to generate double mutant
mice. The Cre enzyme cuts and recombines the
‘ﬂoxed’ DNA at loxP sites. The Cre transgene can be
made inducible, adding more sophistication to the
system. The tamoxifen-inducible CreERT2 which can
be activated in a spatio-temporal manner by adminis-
tration of tamoxifen, is widely used.17 The Cre-loxP
strategy can also be used to regulate the expression of
reporter genes. For example, the lacZ gene can be
driven by a ubiquitous promoter (e.g. Rosa 26) with a
ﬂoxed stop sequence, containing several terminator
codons inserted between the promoter and the lacZ
coding sequence.
Gene editing using nucleases
Over the last 10 years, a number of new techniques have
been developed for the production of targeted muta-
tions using engineered nucleases. These techniques,
brieﬂy described here, provide ES cell-independent
methods to create targeted mutations in laboratory
mice, rats and other species.
To make mutations using zinc-ﬁnger nucleases
(ZFN), two complementary and sequence-speciﬁc
multi-ﬁnger peptides containing the FokI nuclease
domain must be designed. Each peptide is designed to
recognize a speciﬁc DNA sequence spanning 9–18 base
pairs (bp) on either side of a 5–6 bp sequence, which
deﬁnes the targeted region. When injected into a pro-
nucleus or cytoplasm of zygotes, the ZFN assemblies
bind tightly, one on each strand, on both sides of the
target site. The dimerized FokI endonuclease then cre-
ates double strand DNA breaks (DSBs) triggering cel-
lular mechanisms to repair the damage. Damage is
normally repaired by either homology-directed repair
(HDR) or non- homologous end joining (NHEJ).
HDR requires a homologous template to guide the
repair and thus re-establishes the original sequence.
Figure 1. This scheme represents the successive steps in the establishment of a congenic strain. The initial step is a
cross between the donor strain (albino in the example) carrying the gene of interest (e.g. a targeted gene or a transgene)
and a recipient or background strain (black in the example). At each generation, a breeder carrying the gene of interest (*)
is backcrossed to a partner of the recipient strain (genetically linked genes are transferred with it and the size of the
introgressed fragment can be many thousands or millions of bases, and include many genes). The degree of grey colour
indicates that, after each backcross generation, the offspring have an increased amount of the background genome
(average percentage is indicated in each N generation). When the modified gene is not resulting in an easily recognizable
phenotype (e.g. skin or behavioural changes), molecular genotyping is necessary to select the carrier (heterozygous) mice.
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NHEJ is much less precise and cause nucleotide dele-
tions that lead to frame shifts that create potential loss-
of-function or truncation mutations. Mice and rats
carrying null alleles or sequence-speciﬁc modiﬁcations
have already been produced using ZFN technology.18
Like ZFNs, transcription activator-like eﬀector nucle-
ase (TALEN) technology involves the combination of a
nonspeciﬁc DNA endonuclease fused to a DNA-bind-
ing domain, but can be more easily engineered (com-
pared to ZFN) to target a particular DNA sequence.
The CRISPR (clusters of regularly interspaced short
palindromic repeats)/Cas system, commonly imple-
mented as CRISPR/Cas9, is based on a primitive
defence mechanism that allows bacteria and archaea
to ﬁght against infection from viruses, plasmids and
phages.19 CRISPR-based guide RNAs (gRNAs) are
designed to target a Cas endonuclease to cut DNA at
the desired site through RNA-guided DNA cleavage.
The RNA-guided endonucleases can be engineered to
cleave virtually any DNA sequence by appropriately
designing the gRNA, for example to generate KO
mice.20 CRISPR/Cas technology has several advan-
tages over ZFNs and TALENs. The main advantage
is the ease of design and the ﬂexibility of using a
sequence-speciﬁc RNA interacting with the Cas
enzyme instead of a complex sequence-speciﬁc protein
(DNA-binding domain) fused to a nuclease. Also,
mutations in multiple genes can be generated in a
single step by injecting mice with multiple gRNAs
that simultaneously target diﬀerent genes.21 Such multi-
plex gene editing has been successful in cells, as well as
mouse and rat embryos.20 CRISPR/Cas9 has been used
to create insertions, deletions and point mutations. The
system is highly ﬂexible, fast and eﬃcient, and is revo-
lutionizing genomic engineering in mammals.22 It
allows making KO and KI lines in any genetic back-
ground. DNA can be electroporated (with size restric-
tions) or injected into either the cytoplasm or pronuclei
of 1-cell or 2-cell stage embryos, thus avoiding the use
of ES cells and chimeras. However, as each engineered
animal is unique, this technology requires extensive
sequence analysis to characterize multiple putative
founders to ensure the presence of the desired mutation
and the absence of undesired on- and oﬀ-target muta-
tions or unpredictable larger genome alterations,23,24
while also identifying mosaic founders (G0). Once iden-
tiﬁed, the selected founder should be bred with wild-
type animals to evaluate transmission of the mutation.
Spontaneous and chemically-induced
mutations
A list of GA rodent types is not complete without
including both spontaneous and chemically-induced
mutations. Spontaneous mutations, generally identiﬁed
through the observation of an abnormal phenotype,
present several advantages. First and foremost, they
are produced at virtually no cost and are generally
freely available. Second, they usually have an obvious
phenotype, as they are identiﬁed based on observation.
Third, spontaneous mutations represent a great variety
of molecular events, such as deletions, insertions and
point mutations, generating not only loss-of-function
alleles but also hypomorphic and hypermorphic alleles.
Finally, mutations arise in a variety of backgrounds
including inbred strains and outbred stocks. Several
spontaneous mutations have provided rodent models
for human conditions. These include classical muta-
tions such as, nude (Foxn1nu), scid (Prkdcscid), hairless
(Hrhr), diabetes (Leprdb), obese (Lepob) and X-linked
muscular dystrophy (Dmdmdx) in the mouse; and the
mutations behind the Rowett nude (Foxn1rnu) and
Zucker diabetic fatty (Leprfa) models in the rat.
The discovery of the extraordinary virtues of the
alkylating agent N-ethyl-N-nitroso urea (ENU) as a
mutagen was a milestone in the history of mouse gen-
etics. Researchers using ENU have generated and pro-
pagated numerous mutant alleles for protein-coding
genes, thus establishing a precious tool for genome
annotation. Because ENU typically creates point muta-
tions, it has been widely used in forward genetic
screens. The major drawback of ENU-induced muta-
genesis is that it creates random mutations rather than
targeted mutations. Several projects have been under-
taken to systematically and extensively phenotype the
oﬀspring of ENU-mutagenized males. Large ENU
mutagenesis programmes have been conducted in
Germany, England and the USA.25
Quality assurance and exchange
of GA-rodents
What to ensure after (in-house) generation or upon
arrival? The possibility of crossing diﬀerent GA lines
combined with the increasing complexity of targeting
approaches has greatly increased the number of avail-
able GA models. The need to cross diﬀerent GA lines
together for a particular study generates additional
complexity, especially at the genetic background level.
Many mutants have been and are still generated on a
hybrid genetic background. Therefore, it is essential to
keep adequate records of detailed information for all
genetically modiﬁed strains. This information must be
transferred with the strain to all collaborators and
users. The most important information includes the
correct strain name, a complete description of the
mutation, the genetic background of the animals, a
genotyping protocol and observed phenotypic changes.
Together, these provide the minimum information for
the recommended ‘rodent-passport’, and several forms
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have been designed for cataloguing this information.
We recommend the data sheet developed by the
FELASAWorking group on the reﬁnement of methods
for genotyping genetically modiﬁed rodents.26
Every mutant strain name must provide precise
information on the aﬀected gene, the type of mutation
and the genetic background. For in-house generated
strains, one must provide a speciﬁc Institute for
Laboratory Animal Research Laboratory (ILAR)
Code Registration for the laboratory where the
mutant originated. An overview on the importance of
nomenclature can be found in the ‘FELASA guidelines
for the production and nomenclature of transgenic
rodents’.27 A name designed according to the inter-
national nomenclature rules is the only means to unam-
biguously distinguish strains from each other. This is
important when the same strain is held in diﬀerent facil-
ities around the world and/or they are listed in archives
and databases. Further, it is imperative that strains be
properly described in publications using a universal
nomenclature. Without a common nomenclature, it
becomes impossible to accurately communicate scien-
tiﬁc results. Vague or incomplete names create errors
rendering experiments irreproducible.
Origin and consequences of genetic
variation
A serious challenge facing rodent animal facilities is
keeping inbred strains genetically pure and GA lines
on a deﬁned background. Changes in the genetic con-
stitution of inbred strains can be produced by (a) con-
tamination by accidental outcrosses and (b) genetic
drift due to residual heterozygosity or ﬁxation of de
novo spontaneous mutations.
Genetic contamination
The accidental mating of individuals from one inbred
strain with animals of another origin is by far the most
important source of genetic proﬁle alteration in inbred
strains. Genetic contamination of this type, which
always results in a sudden and massive exchange of
alleles, is more likely between strains that have similar
coat colour (i.e. albino (Tyrc/Tyrc), agouti (A/A), or
non-agouti (a/a)). Where lines have the same coat
colour alleles, extra care must be taken when housing
them in close proximity of each other.
Spontaneous mutations and polymorphisms
Spontaneous mutations are a source of uncontrolled
genetic variation that is often impossible to detect by
simple phenotypic observation or routine genetic moni-
toring (GeMo). Genetic polymorphism is the presence of
alternative DNA sequences (alleles) at a locus among
individuals, groups, or populations, at a frequency
>1%. Two types of genetic markers are commonly
used in association studies and genetic quality control:
microsatellites and single nucleotide polymorphisms
(SNPs) (see ‘Marker systems’ below).
Genetic drift and the generation
of substrains
While permanent inbreeding eﬀectively eliminates a
proportion of new mutant alleles, another undetected
fraction may become progressively ﬁxed in the homo-
zygous state, replacing the original allele, a process
known as genetic drift. Genetic drift contributes inex-
orably to strain divergence and the generation of sub-
strains when the same strain is propagated
independently in diﬀerent places.28 Examples of
mouse substrains are abundant, for example there are
c. 10 documented BALB/c substrains and c. 15 C57BL/
6 substrains including the J and N substrains from The
Jackson Laboratory (Jax) and the National Institutes
of Health (NIH), respectively.29 In the same way, many
rat inbred strains present at least two substrains, for
example SHR has at least four substrains (including
SHR/Ola and SHR/NCrl), and WKY and F344 have
at least three substrains each. Substrain variability has
been conﬁrmed by sequencing analysis for these rat
substrains,30 with WKY showing the highest degree
of substrain variation (this is in part due to the
supply of the model prior to the prescribed 20 gener-
ation inbreeding requirement).
Undesirable passenger mutations
Mutations that are hidden in the genomes of substrains
or GA lines and can aﬀect the outcome of an experi-
ment are sometimes referred to as passenger muta-
tions.31 There are many examples in the literature
where substrains originating from the same inbred
strain have acquired new phenotypes as a consequence
of genetic drift.32 For example, mice of the C57BL/
6JOlaHsd substrain are homozygous for a deletion of
the a-synuclein (Snca) and multimerin (Mnrn1)
genes.33,34 Likewise, some spontaneous mutations dif-
ferentially segregate in C57BL/6J and C57BL/6N, the
most common substrains of C57BL/6, separated in
1951. These include a retinal degeneration mutation
in the Crb1 gene (Crb1rd8), present only in the N sub-
strain, and a deletion in the Nnt gene, present only in
the J substrain.35,36 Berghe and colleagues recently
reported that passenger mutations are also common
in most GA lines derived from 129 ES cells, and that
these mutations persist even after the creation of fully
congenic strains.37 This is not trivial; Berghe et al.
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estimated that close to 1000 protein-coding genes could
be aberrantly expressed in the 129-derived chromo-
somal segments that are still segregating in these con-
genic lines. This ﬁnding emphasizes the need for
properly chosen control animals to identify phenotypes
due to background mutations or the combination of
background mutations and the genetic modiﬁcation of
interest, rather than the modiﬁcation itself.
Importance of using standard
nomenclature
Rules guiding nomenclature were established by the
International Committee on Standardized Genetic
Nomenclature for Mice and Rats and are continuously
updated. These rules, last revised in January 2016, are
described on the MGI webpage under ‘Guidelines for
Nomenclature of Mouse and Rat Strains’ (http://www.
informatics.jax.org/mgihome/nomen/strains.shtml). A
helpful and visual Mouse Nomenclature Quick Guide
is available at https://www.jax.org/jax-mice-and-ser-
vices/customer-support/technical-support/genetics-
and-nomenclature#. For more details on nomenclature
refer to the Supplementary material.
Genetic quality control programmes
The current gold standard for genetic quality control of
laboratory rodents depends on polymorphic genetic
markers to distinguish between diﬀerent genetic back-
grounds. Genetic markers are speciﬁc DNA sequences
with a known location on a chromosome and are essen-
tial tools for genetic quality control. Genetic quality
control is essential to determine the genetic compos-
ition of an animal and to screen for uniformity and
authenticity of a strain. Please note that outbred colo-
nies cannot be tested for authenticity. Instead, the
colony is screened for its level of genetic heterogeneity
to detect genetic contamination and to monitor the pro-
gress of breeding programmes and to select future
breeders.
Marker systems
Many polymorphisms have been described in the
mouse and rat; however, only microsatellites and
SNPs are used as genetic markers in current QA pro-
grammes. Microsatellite markers, also known as Simple
Sequence Length Polymorphisms (SSLPs) or Short
Tandem Repeats (STRs), are still used in modern
GeMo programmes because they are inexpensive and
easy to type.38,39 Animals are genotyped by analysing
PCR-products ampliﬁed from short, tandemly
arranged, repeating DNA sequences. These repeats
are typically 2–6 bp long and are repeated a few to
dozens of times creating allelic diversity among stains.
Genomic DNA primers are designed to unique
sequences ﬂanking the repeats. The PCR products, typ-
ically around 100–300 bp in size, are analysed using
agarose or polyacrylamide gel electrophoresis. The
MGI webpage has comprehensive SSLP information,
including primer sequences and size variations in bp
for several inbred mouse strains (http://www.informat-
ics.jax.org/marker). A collection of mapped, highly
polymorphic, SSLP markers for inbred laboratory rat
strains is available in The National BioResource
Project – Rat database and is linked to the Map
Report of the Rat Genome Database (RGD) (http://
rgd.mcw.edu). See Supplementary Table 2 for the com-
plete list of online resources for laboratory mouse and
rat strains.
SNP genotyping is an alternative to microsatellites
that is now widely used for GeMo. SNP genotyping is
inexpensive and can be performed in most research
institutions or outsourced. SNPs are the most
common genetic variation and exist in both coding
and non-coding regions. Almost all SNPs are bi-allelic,
presenting one of only two possible nucleotides (e.g.
homozygous G/G or T/T), or both (e.g. heterozygous
G/T) in an individual. Petkov and co-workers from The
Jackson Laboratory have described the allelic distribu-
tion of 235 SNPs in 48 mouse strains and selected a
panel of 28 SNPs suﬃcient to characterize the majority
of the c. 300 inbred, wild-derived, congenic, consomic
and recombinant inbred strains maintained at The
Jackson Laboratory.40 Several publications have
reported useful SNPs for the rat. For example,
Zimdahl and colleagues described a map with
>12,000 gene-based SNPs from transcribed regions.41
GeMo of inbred strains and outbred stocks
Most GeMo techniques used currently are based on
microsatellites or SNPs. However, GeMo should not
rely solely on molecular techniques, but should take a
broader view that includes phenotypic parameters such
as coat colour, behaviour and breeding performance.
Commercial breeders are extremely sensitized to the
risk of genetic contamination and regularly monitor
their strains for genetic contamination, but not neces-
sarily genetic drift, by using diﬀerent sets of SNPs to
monitor their nucleus colonies. The Jackson
Laboratory incorporated a unique, patented, Genetic
Stability Program42 designed to eﬀectively limit cumu-
lative genetic drift by rebuilding their foundation stocks
from pedigreed, cryopreserved embryos every ﬁve gen-
erations. For example, starting in 2005, they began sell-
ing only C57BL/6J mice derived from two chosen mice
through hundreds of frozen embryos of the duo’s
grandchildren (enough to last for 25–30 years). It
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should be noted that when recovering strains from
frozen stocks good GeMo should be carried out to
assure oneself that genetic contamination or wrong
genotypes were not present prior to freezing.
For outbred stocks, GeMo helps preserve the genetic
heterogeneity and allele pool of a colony. This complex
process requires analysing a large number of animals
and comparing this data with historical data document-
ing the alleles present, their frequency and the level of
heterozygosity in that particular colony. In some cases,
the results can reveal a loss of genetic variability result-
ing in a colony with very low heterogeneity. The degree
of genetic heterogeneity in outbred colonies depends on
their history. Low heterogeneity can result from poor
selection of future breeding stock, deviation from
approved (rotational) breeding systems or the bottle-
neck eﬀect caused by a small breeding pool, as is
common when a small group of breeders is imported
or being used to rederive a colony. In contrast, high
heterogeneity can result from a recent outcross. In gen-
eral, outbred stocks are characterized by measuring
phenotypic traits and calculating the corresponding
mean and standard deviations. Essentially, genetic con-
trol of outbred stocks is directed at avoiding inbreeding
and stabilizing genetic diversity over many generations.
GeMo of inbred mice and rats bred in-house. The
best recommendation here is to purchase animals
from reliable vendors and replace the breeding stock
with animals from the same vendor after 10 gener-
ations, rather than to maintain independent colonies
of classical inbred strains. As an additional beneﬁt,
using animals from the same vendor prevents the for-
mation of substrains harbouring potential mutations
and maintains a similar microbiome. Nevertheless, in-
house colonies should always be tested with a small set
of informative microsatellite markers or SNPs to con-
ﬁrm integrity.
Using a small panel of microsatellites
(SSLPs). Microsatellites can be used to verify that the
animals in an inbred colony are essentially pure, with
no traces of genetic contamination. This is especially
important in facilities that maintain strains with the
same coat colour in the same room, a particularly dan-
gerous practice especially when not using individually
ventilated cage (IVC) systems. Microsatellite testing
can normally be performed in-house. The number of
markers to use for testing has not been standardized:
each situation and facility diﬀers in how many and
which strains are kept. Nonetheless, a panel of 40 poly-
morphic SSLPs, evenly distributed across the auto-
somes, will rule out recent genetic contamination, if
the markers can distinguish among the strains being
analysed. Supplementary Table 3 presents a small set
of mouse SSLPs that could be used to authenticate
some classical inbred strains.
Interpreting SSLP data is straightforward. Because
inbred animals are isogenic and homozygous, they will
present only one band in the electrophoresis gel, repre-
senting a single allele, when genotyped for a particular
SSLP. The presence of any heterozygosity, indicated by
two bands, or bands that do not coincide with those of
the strain control DNA, should be considered as indi-
cating potential strain contamination (Figure 2). How
frequently colony strain identity should be evaluated
depends on the size of the colony, the generation inter-
val, etc. Generally, testing once every two years is rea-
sonable for a facility maintaining a small number of
colonies well-separated in terms of coat colour, and
with low numbers of importations.
Using a small panel of SNPs. For GeMo purposes
only, 40 polymorphic SNPs, evenly distributed across
the chromosomes is a reasonable number for detecting
recent genetic contamination (this suggestion should be
modiﬁed dependent on the conditions or risks in each
facility). SNP genotyping is currently available on dif-
ferent platforms, that vary in cost and automation cap-
abilities. Kompetitive Allele Speciﬁc PCR (KASP), a
variation on allele-speciﬁc PCR, uses allele-speciﬁc
oligo extension and ﬂuorescence resonance energy
transfer,43 has the advantage that it can be automated
using 96- or 384-well plates and pipetting robots for the
PCR reactions (Supplementary Figure 3). Another
option, real-time PCR (TaqMan) technology, uses
speciﬁc primers coupled with a sequence-speciﬁc, ﬂuor-
escent TaqMan probe, is eﬀective and easy to auto-
mate; however, the cost per individual assay is
expensive compared with KASP assays, and requires
a more costly real-time thermocycler. Finally, microar-
ray-based SNP genotyping is not typically used for
small scale, in-house GeMo, but may be an option
for vendors of inbred mice. When using or requesting
microarray genotyping services, be aware that only a
percentage of the SNPs will be polymorphic between
the strains under analysis (e.g., c. 40% for some clas-
sical inbred strain combinations). Information regard-
ing which alleles (C, G, A or T) to expect for a
particular SNP/strain combination, and their genomic
location are available for hundreds of thousands of
SNPs and for the common mouse and rat inbred strains
in easily accessed databases and genome browsers
(Supplementary Table 2).
GeMo of outbred colonies. GeMo of outbred stocks is
much more complex, because these animals are not gen-
etically uniform. Outbred colonies are essentially a
group of closely related animals, with shared ancestors
and group identity, but that exhibit some level of
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genetic heterozygosity. Since outbred colonies form a
population rather than a strain, it is diﬃcult to establish
a standard GeMo programme with only a few genetic
markers. However, with an adequate number of SNPs
or SSLPs, allele frequencies within the population
could indicate the identity of the stock.44 One of the
main problems of in-house outbred stocks is that they
are often maintained with a very small number of
animals in the breeding colony, causing a reduction
of alleles represented in the population. This may
impact genetic drift and increase the inbreeding
coeﬃcient. Such colonies are neither truly outbred
nor inbred. Although SSLPs or SNPs can be used to
estimate the level of heterozygosity within the colony,
if it is not possible to keep an appropriate number
of breeders, it is better to purchase outbred
Figure 3. This chart explains the typical timeline for a marker assisted (speed congenic) backcross process. The pre-
diction of >98% recipient genome at N5 is based on the use of 20 best breeders (carriers) at each generation,55 however,
this number is not always available and fewer breeders can be used, with disparate results, depending also on chance. PI:
Principal Investigator (laboratory). Service: the laboratory providing the genome scan with SNP markers.
Figure 2. Example of genetic contamination detected by SSLP PCR. The picture shows a 4% agarose gel with the
characteristic bands obtained after PCR amplification using genomic DNA from four mice supposedly belonging to the
BALB/c strain (first four lanes), plus a standard DNA control for BALB/c (last lane). In this example, only five SSLP loci are
shown, located in chromosomes 1 to 5. Note the presence of heterozygosity (two bands) and homozygosity for bands that
do not match the standard for BALB/c. This is a clear case of loss of authenticity due to genetic contamination. The PCR
products are compared with a 100 bp DNA ladder.
Benavides et al. 9
rodents from vendors that maintain a very large colony
and use recommended breeding schemes to reduce
inbreeding.
Background characterization (BC) for GA
and mutant lines
The explosion in the number of GA lines is exacerbat-
ing the problem of undeﬁned ‘mixed backgrounds’ in
experimental rodents. This is particularly worrisome
for inducible and conditional models that require the
crossing of two independent lines (e.g. Cre-expressing
lines crossed with ﬂoxed lines). Given that genetic
background inﬂuences phenotype, especially through
the inﬂuence of modiﬁer genes; mutations, both spon-
taneous and induced, transgenes, and targeted
alleles that are introgressed into a new background
may not exhibit the expected phenotype.45,46 One of
the ﬁrst cases reporting this phenomenon involved the
classical diabetes (Leprdb) mutation that presented
transient diabetes in a C57BL/6 background but
overt diabetes in C57BLKS.47 Other examples
include background eﬀects on survival rate in Egfr
(epidermal growth factor receptor) KO mice48 and
tumour incidence in Pten KO mice.49 For this reason,
every GA line should be characterized in terms of
their genetic background. Moreover, the knowledge
of the genetic background of a mutation is also import-
ant for the selection of the corresponding control
animals.50
Genetic markers evenly distributed and covering the
entire genome can be used in a genome scan to estimate
the percentages of genome coming from diﬀerent
inbred origins. This process of BC is provided by
some commercial enterprises and institutional core
facilities. A typical BC employs polymorphic markers
to distinguish between the suspected inbred strains. In
most mouse cases, these strains are C57BL/6 and 129
substrains because, historically, the ES cells used for the
development of KO and KI mice through homologous
recombination (section ‘‘Targeted mutagenesis by
homologous recombination using ES cells’’ above)
were derived exclusively from 129 substrains51 whereas
WT C57BL/6 females were typically used to prove
germline transmission from the chimeras. Without sub-
sequent backcrosses, this scheme resulted in a B6;129
mixed background. However, the availability of ES cell
lines derived from other strains (particularly from
C57BL/6) and the arrival of genome editing techniques
(section ‘‘Gene editing using nucleases’’) that allow
direct production of targeted alterations in any mouse
or rat strain52 is slowly changing this scenario. In any
case, the problem of mixed background can be circum-
vented altogether by (a) injecting transgenes or nucle-
ases (Cas9-sgRNA) into inbred embryos from the
strain of choice; (b) modifying the gene of interest in
ES cells from the preferred background strain (e.g.
using C57BL/6 ES cells); and (c) crossing chimeras
and KO/KI founders with mice of the same strain as
the ES cells used for the targeting. Finally, if the GA
line has already been developed or acquired from a
collaborator or repository, a BC should be per-
formed, and if needed, a fully congenic strain should
be developed, either by classical or marker-assisted
backcrossing. Periodic backcrossing of a congenic
strain to the background strain (of reputable source)
also minimises divergence and keeps the congenic
strain genetically close to the strain background of con-
trol animals.
Marker-assisted backcrossing for quality
assurance and refinement
The use of DNA markers has allowed for a much more
rapid and rigorous process of congenic strain develop-
ment called marker-assisted backcrossing or speed con-
genics.53 This process relies on using polymorphic
genetic markers covering the whole genome to deter-
mine the percentage of donor genome present in the
animals, then selecting the animals with the lowest
percentage of donor DNA for the next backcross to
the recipient strain. This relies on the regions between
the polymorphic genetic markers being those of the
donor genome: the denser the number of markers the
higher the donor genome can be inferred. Common
practice is the use of 100–300 markers. This process
reduces the number of generations to reach full con-
genicity (e.g. from N10 to N5), and therefore strain
development time, by approximately half. Using
marker-assisted backcrosses and the right number of
animals we can obtain c. 80% recipient background at
N2, c. 94% at N3, and c. 99% at N4 (compared to the
classical mean values of 75.0, 87.5 and 93.7%). A
ﬂowchart depicting a standard speed congenic proto-
col is shown in Figure 3. Ideally, the backcross pro-
cedure is started with a donor female and a recipient
male. Then, F1 mutant males will carry the correct
Y-chromosome and after mating to a recipient
female, males of the N2 generation will carry the cor-
rect X- and Y-chromosome of the recipient strain
(avoiding the use of genetic markers on these chromo-
somes).54 It was predicted by Markel et al. that if 20
best breeders (carriers) are used at each generation of
the speed congenics protocol >98% recipient gen-
ome can be attained at N5.55,56 However, the chromo-
somal segments ﬂanking the selected locus tend to
remain associated with it and this is a limitation of
the congenic lines due to the potential presence
of modiﬁer genes in this segments, the so-called
‘ﬂanking gene problem’.57
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Genetic stability and cryopreservation
programmes
For inbred, co-isogenic and congenic strains, breeding
methods and genetic stability programmes help to min-
imize substrain divergence due to genetic drift, and also to
prevent genetic contamination by accidental crosses with
other strains. To reduce genetic drift, the number of gen-
erations of in-house breeding should be minimized, and
the lines submitted to repositories such as, JAX, EMMA,
MMRRC, IMSR or RIKEN, to be archived as frozen
embryos and/or sperm. This secures the line and provides
a means of replacing the breeding stock every 10 gener-
ations as recommended by The Jackson Laboratory
Genetic Stability Program (GSP) in order to slow down
cumulative genetic drift.42 For outbred stocks, the intent
is to minimize inbreeding, maintain heterozygosity and
manage genetic drift that would otherwise lead to
colony divergence. Ideally, outbred colonies should be
maintained with 25 breeding pairs, all of which have
to contribute to the next generation, in order to avoid
an increase of the inbreeding coeﬃcient per generation
of more than 1%. Smaller colonies drift fast toward
homozygosity because breeders are closely related.58
Cryopreservation strategies have been adopted for
long-term storage of embryos and gametes in several
large centralized repositories including the EMMA/
INFRAFRONTIER (European Mutant Mouse
Archive), the Knock Out Mouse Project (KOMP)
Repository, The Jackson Laboratory Repository, The
Center for Animal Resources and Development
(CARD) and the Riken Bio Resource Center, which
can provide cryopreserved material or live mice to
laboratories. These repositories facilitate the availabil-
ity of these strains to the worldwide scientiﬁc commu-
nity and provide a backup for a potential loss of a
strain. The International Mouse Strain Resource
(IMSR) is a searchable online database of mouse
strains, stocks and mutant ES cell lines available world-
wide, including inbred, mutant and genetically engin-
eered strains (http://www.ﬁndmice.org/).
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Re´sume´
L’assurance qualite´ (AQ) ge´ne´tique, dont la surveillance ge´ne´tique (SG) des souches consanguines
et la caracte´risation des souches (CS) de mode`les animaux ge´ne´tiquement modifie´s (GM) devrait
constituer un aspect essentiel de tout programme d’AQ dans les installations de recherche animale. Le
controˆle qualite´ ge´ne´tique est aussi important que la surveillance sanitaire ou microbiologique pour assurer
la validite´ du mode`le animal. Il devrait eˆtre obligatoire que les e´tudes utilisant des rongeurs de laboratoire,
principalement des souris et des rats, utilisent des animaux ge´ne´tiquement de´finis. Le document pre´sente´
par le groupe de travail FELASA sur l’assurance qualite´ et la surveillance ge´ne´tiques des rats et souris de
laboratoire, de´crit les objectifs et les me´thodes disponibles pour les programmes d’AQ mene´s dans les
installations utilisant des rongeurs. Les objectifs principaux d’un programme d’AQ sont les suivants :
(i) ve´rifier l’authenticite´ et l’uniformite´ des souches consanguines et des sous-souches, assurant ainsi la
maintenance d’une colonie ge´ne´tiquement fiable; (ii) de´tecter les contaminations ge´ne´tiques e´ventuelles;
et (iii) de´crire pre´cise´ment la composition ge´ne´tique des ligne´es GM. Bien que cette publication se concentre
sur l’AQ ge´ne´tique des souris et des rats, les principes s’appliqueront a` d’autres espe`ces de rongeurs,
dont certaines sont brie`vement mentionne´es dans le contexte des animaux issus de ligne´es consanguines
ou croise´es.
Abstract
Die genetische Qualita¨tssicherung (QA), einschließlich des genetischen Monitorings (GeMo) von
Inzuchtsta¨mmen und der Hintergrundcharakterisierung (BC) von genetisch vera¨nderten (GA) Tiermodellen,
sollte generell ein wesentlicher Bestandteil aller QA-Programme in Versuchstiereinrichtungen sein. Die
genetische Qualita¨tskontrolle ist zur Gewa¨hrleistung der Validita¨t von Tiermodellen ebenso wichtig wie die
U¨berwachung ihrer Gesundheit und mikrobiologischen Qualita¨t. Fu¨r Studien mit Labornagern, hauptsa¨chlich
betrifft es Ma¨use und Ratten, sollte ausschließlich die Verwendung von genetisch definierten Tieren vorge-
sehen werden. Dieses Dokument, das von der FELASA Arbeitsgruppe u¨ber genetische Qualita¨tssicherung und
genetisches Monitoring von Laborma¨usen und -ratten pra¨sentiert wird, beschreibt die Ziele und verfu¨gbaren
Methoden fu¨r genetische QA-Programme in Labortierhaltungen. Die Hauptziele eines jeden genetischen QA
Programms sind: (i) U¨berpru¨fung der Authentizita¨t und Uniformita¨t von Inzuchtsta¨mmen und deren
Substa¨mme, um so eine genetisch zuverla¨ssige Erhaltung der Kolonie zu gewa¨hrleisten, (ii) Erkennung
mo¨glicher genetischer Kontaminationen, und (iii) pra¨zise Beschreibung der genetischen Beschaffenheit von
GA-Linien. Diese Vero¨ffentlichung konzentriert sich hauptsa¨chlich auf die genetische QA von Maus und Ratte,
wobei die Prinzipien auch fu¨r andere Nagetierarten, von denen einige im Zusammenhang mit Inzucht- und
Auszuchtsta¨mmen kurz erwa¨hnt werden, zutreffen.
Abstract
La garantı´a de calidad gene´tica (QA), incluidos el monitoreo gene´tico (GeMo) de las cepas consanguı´neas y la
caracterizacio´n de fondo gene´tico (BC) de los animales gene´ticamente modificados (GA), deberı´a ser un
componente esencial de cualquier programa de QA en los animalarios de roedores. El control de la calidad
gene´tica es tan importante para asegurar la validez del modelo animal como lo es el control de calidad
sanitaria y microbiolo´gica. Deberı´a exigirse que los estudios que utilicen roedores de laboratorio, principal-
mente ratones y ratas, utilicen exclusivamente animales gene´ticamente definidos. Este manuscrito, presen-
tado por FELASA Working Group on Genetic Quality Assurance and Genetic Monitoring of Laboratory Murines,
describe los objetivos y me´todos disponibles para los programas de calidad gene´tica en instalaciones de
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roedores de laboratorio. Los principales objetivos de cualquier programa de calidad gene´tica son: (i) verificar
la autenticidad y uniformidad de las cepas (y sub-cepas) consanguı´neas; (ii) detectar una posible contamina-
cio´n gene´tica; y (iii) describir con precisio´n la composicio´n gene´tica de las lı´neas gene´ticamente modificadas.
Si bien esta publicacio´n se centra principalmente en los controles de calidad gene´tica de ratones y ratas, los
mismos principios se aplican a otras especies de roedores de laboratorio, algunas de las cuales se mencio-
nan brevemente en el contexto de las cepas consanguı´neas y los grupos exocriados de ratones y ratas.
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